The impact of expanded endonasal skull base surgery on midfacial growth in pediatric patients

Arjun K Parasher1,2, David K Lerner3, Jordan T Glicksman4,5

  • 1Department of Otolaryngology-Head and Neck Surgery, University of South Florida, Tampa, Florida, U.S.A.

The Laryngoscope
|May 10, 2019
PubMed

Insights

The expanded endonasal approach (EEA) for pediatric skull base tumor resection does not negatively impact midfacial growth. This minimally invasive technique shows comparable outcomes to traditional open surgery regarding facial development.

Area of Science:

  • Pediatric Neurosurgery
  • Craniofacial Surgery
  • Skull Base Surgery

Background:

  • Expanded endonasal approach (EEA) is increasingly used for pediatric skull base tumor resection.
  • Concerns exist regarding potential iatrogenic damage to nasal growth zones and its effect on midfacial growth.

Purpose of the Study:

  • To evaluate the effect of EEA on midfacial growth in pediatric patients.
  • To compare midfacial growth following EEA versus open transcranial approaches for tumor resection.

Main Methods:

  • Retrospective review of pediatric patients undergoing craniopharyngioma resection.
  • Comparison between EEA (n=12) and open transcranial approach (n=10).
  • Pre- and postoperative MRI analysis of midfacial measurements (anterior/posterior height, palatal length, sella-nasion distance) over 3 years.

Main Results:

  • No significant difference in midfacial growth was observed between EEA and open transcranial groups.
  • Specific measurements (anterior midface height, posterior midface height, palatal length, sella-nasion distance) showed no statistically significant divergence between the surgical approaches.

Conclusions:

  • EEA is a safe alternative to traditional transcranial approaches for pediatric skull base tumor resection concerning midfacial growth.
  • Further long-term studies with larger cohorts are needed to fully elucidate the implications of EEA on skull base development.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
214
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
276
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
200
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
261
Sutures of the Skull01:22

Sutures of the Skull

The human skull is composed of several bones that come together to protect the brain and support the structures of the face. The junctions where these bones meet are called sutures.
Sutures are immobile joints between adjacent bones of the skull. The narrow gap between the bones is filled with dense, fibrous connective tissue that unites the bones. The long sutures located between the skull bones are not straight but instead follow irregular, tightly twisting paths. These twisting lines tightly...
10.3K
Overview of the Skull01:08

Overview of the Skull

The cranium (skull) is the skeletal structure of the head that supports the face and protects the brain. It is subdivided into the facial bones and the brain case, or cranial vault. The facial bones underlie the facial structures, form the nasal cavity, enclose the eyeballs, and support the teeth of the upper and lower jaws.
The cranial vault surrounds and protects the brain and houses the middle and inner ear structures. This cavity is bounded superiorly by the rounded top of the skull, which...
7.6K